Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is... see more

CSE:HUGE - Post Discussion

FSD Pharma Inc > Let’s talk about something for this week
View:
Post by DavidRosenberg on Oct 25, 2021 7:54am

Let’s talk about something for this week

Why was lucid acquired with stock versus cash

here is my opinion on the matter , let's keep it civil this week , no basher or pumper nonsense 

I want to see if you guys have decency to carry on a proper conversation at least for this week without pointing fingers


Lucid was acquired with stock instead of cash

Tim Arslan I think they used shares because value wise was above $2.50, which is substantially above market price so better value to everyone ,if the share price was higher then you would use cash not shares to do acquisition … whatever the best deal is for that target I think is what the company did to acquire it

Also the share price sucking right now is what FSD is working on right now , they have a lot of skin in the game  and would want to see it go up as much as we do
Comment by Walter333 on Oct 25, 2021 9:04am
They have a lot of skin in the game? Sure insiders have made a purchase here and there, however the majority of their so called "skin" in the game has come by way of the free options that they continually grant themselves. While constantly and consistently failing, the free granted options are hardly skin in the game and more of an attempt at a cash grab imo. Class B shareholders are the ...more  
Comment by Walter333 on Oct 25, 2021 9:37am
Do I doubt cannabis and it's potential for medicines, no. Do I doubt PEA and it's potential uses, no. Do I doubt psychedelics and their potential uses in future medicines/treatments, no. Do I have doubts that a gambling banker and a pumping DJ have shareholders best interest at heart, yep.
Comment by DavidRosenberg on Oct 25, 2021 9:39am
FYI , Goldman Sachs CEO is a musical artist too 
Comment by Mil_Man54 on Oct 25, 2021 10:18am
So what successful company are you the CEO of Rosenberg.....you know since you and the CEO of Goldman Sachs both like music.....and btw.....I don't consider a DJ to be a musical artist.......
Comment by Walter333 on Oct 25, 2021 10:36am
Mr Rosenberg, are you now attempting to compare yourself to the CEO of Goldman Sachs as you do with FSD Pharma to other successful companies? Perhaps you could volunteer for the Lucid Psych trials.
Comment by Mil_Man54 on Oct 25, 2021 10:41am
Someone call the burn unit....they have incoming.....LOL.....
Comment by DavidRosenberg on Oct 25, 2021 11:10am
that was a joke in response to your DJ Comment  If you want facts about the company  you can know that they have $43.1M USD in the bank ready to rock n roll with clinical trials
Comment by Mil_Man54 on Oct 25, 2021 11:49am
So much for actual discussion.....you're right back to posting the same PR BS......you post an opinion....we counter and you go right back to this mindless reposting of this propoganda of someone elses that you continually hide behind.....and then you get all defensive when you get called out as a pumper......maybe you should stop posting like one......
Comment by Mil_Man54 on Oct 25, 2021 11:50am
And it pathetic that you give yourself thumbs up with your other accounts.....
Comment by DavidRosenberg on Oct 25, 2021 12:00pm
Those are not my accounts i keep telling you , why do you keep repeating the same thing, maybe if you say it 1,000,000 times more then it will be true? I only use one account which is this one 
Comment by Renofund on Oct 25, 2021 12:01pm
Are you on here more now because you have been temporarily suspended on CEO.ca? LOL
Comment by Mil_Man54 on Oct 25, 2021 1:58pm
Was someone a bad pumper on CEO.ca and got themselves suspended.....I wish Stockhouse was as strict....that would clean up this board quite a bit and we could have some actual intellligent conversations instead of calling out these clowns all day....
Comment by CurtMiller on Oct 25, 2021 5:39pm
Agreed, we should have better conversations around FSD pharma. Many of us want FSD to get better results, we have our money there. The psychedelics may seem like the perfect market, but is this the perfect time? I hope FSD strategy is what that everyone is waiting.
Comment by Mil_Man54 on Oct 25, 2021 1:56pm
Of course you have multiple pumper accounts on this board and likely others.  You can deny it all you want but the word is out......
Comment by DavidRosenberg on Oct 25, 2021 2:43pm
  the word is out you aren't a shareholder 
Comment by Mil_Man54 on Oct 25, 2021 3:02pm
Oh you got me......I've been playing the shorter long game for the past 3 years just waiting for my moment to pounce.......luckily I was able to make FSD fail twice and I'm working on the third......idiot....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities